Article Text

Download PDFPDF
Highlights from the literature: inflammatory bowel disease

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.


  • Contributors RM is the sole contributor to this paper.

  • Competing interests RM has received speaker fees, travel support and research grants, or has performed consultancy work with MSD Immunology, AbbVie, Dr Falk Pharma, 4D Pharma, Tillotts Pharma, Nestle, Takeda, Ferring and Pfizer.

  • Patient consent Not required.

  • Provenance and peer review Not commissioned; externally peer reviewed.